# US 2013/0280693 A1 · Density-based separation of biological analytes using multiphase systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0280693 A1
- Document ID: US20130280693A1
- Status: Published application
- Kind: A1
- Application number: 13/817,985
- Filed: 2011-08-22
- Published: 2013-10-24
- Earliest claimed: 2010-08-20
- Assignees: President and Fellows of Harvard College a University
- Inventors: Charles R. Mace; Ashok A. Kumar; Dyann F. Wirth; George M. Whitesides
- Web page: https://patentgrep.com/patent/US20130280693A1

## CPC

- G01N 33/491: {by separating the blood components (G01N15/05 takes precedence)}
- B03B 5/28: by sink-float separation
- B03B 5/442: {composition of heavy media}
- B03D 3/00: Differential sedimentation
- G01N 33/18: Water
- G01N 33/5375: {by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning}
- G01N 33/5759: {involving compounds localised on the membrane of tumour or cancer cells}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B03B: SEPARATING SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS
- B03D: FLOTATION; DIFFERENTIAL SEDIMENTATION (sedimentation in general B01D21/00; in combination with other separation of solids B03B; sink-float separation B03B5/28; detergents, soaps C11D)

## Abstract

The disclosed methods use a multi-phase system to separate samples according to the density of an analyte of interest. The method uses a multi-phase system that comprises two or more phase-separated solutions and a phase component such as a surfactant or polymer. The density of the analyte of interest differs from the densities of the rest of the sample. The density of the analyte of interest is substantially the same as one or more phases. Thus, when the sample is introduced to the multi-phase system, the analyte of interest migrates to the phase having the same density as the analyte of interest, passing through one or more phases sequentially.

## Claims

### Claim 1

A method of analyzing or separating a sample comprising one or more biological analytes of interest using a multi-phase system, comprising:
a) providing a multi-phase system comprising two or more phase-separated solutions, wherein
each phase comprises a phase component selected from the group consisting of a polymer, a surfactant and combinations thereof, wherein at least one phase comprises a polymer;
each said phase has an upper and a lower phase boundary; and
each of the two or more phases has a different density and the phases, taken together, represent a density gradient; and
b) introducing a biological sample comprising one or more biological analytes of interest without disrupting the phase-separated solution; and
c) allowing each of the biological analytes to migrate to a location in the multi-phase system that is characteristic of its density, wherein during migration the sample contacts one or more of the two or more phases sequentially.

### Claim 2 (depends on 1)

The method of claim 1, wherein the at least two phases share a common solvent.

### Claim 3 (depends on 2)

The method of claim 2 wherein the multi-phase system is an aqueous system and the common solvent is an aqueous solvent.

### Claim 4 (depends on 1)

The method of claim 1, wherein the multi-phase system is a non-aqueous system and the common solvent is an organic solvent.

### Claim 5 (depends on 1)

The method of claim 1, wherein the phase components are selected to be biologically compatible.

### Claim 6 (depends on 1)

The method of claim 1, wherein the biological sample comprises cells.

### Claim 7 (depends on 1)

The method of claim 1, wherein the cells are selected from the group consisting of animal, plant, protozoan, and prokaryotic cells.

### Claim 8 (depends on 6)

The method of claim 6, wherein one or more phases comprises a lysing agent to cause the cells to lyse, the biological analyte of interest being recovered from cell lysate.

### Claim 9 (depends on 1)

The method of claim 1, wherein the biological analyte is selected from the group consisting of organelles, cell fragments, cell membranes, cell membrane fragments, viruses, virus-like particles, bacteriophage, cytosolic proteins, secreted proteins, signaling molecules, embedded proteins, nucleic acid/protein complexes, organelles, minicells, nucleic acid precipitants, chromosomes, nuclei, mitochondria, chloroplasts, flagella, biominerals, protein complexes, and protein aggregates.

### Claim 10 (depends on 1)

The method of claim 1, wherein the biological sample comprises one or more parasites selected from the group consisting of worms, insects, protozoa, arachnids, and arthropods.

### Claim 11 (depends on 1)

The method of claim 1, wherein the biological sample comprises a biological fluid.

### Claim 12 (depends on 1)

The method of claim 1, wherein the biological sample is selected from the group consisting of food, juice, and milk.

### Claim 13 (depends on 12)

The method of claim 12, wherein the biological sample is tested for contaminants selected from the group consisting of pathogens, pests, heavy metals, and pesticides.

### Claim 14 (depends on 1)

The method of claim 1, wherein the biological sample comprises one or biological carriers selected from the group consisting of whole blood, plasma, serum, sweat, feces, urine, saliva, tears, vaginal fluid, prostatic fluid, gingival fluid, amniotic fluid, intraocular fluid, cerebrospinal fluid, seminal fluid, sputum, ascites fluid, pus, nasopharengal fluid, wound exudate fluid, aqueous humour, vitreous humour, bile, cerumen, endolymph, perilymph, gastric juice, mucus, peritoneal fluid, pleural fluid, sebum, vomit, and combinations thereof.

### Claim 15 (depends on 1)

The method of claim 1, wherein the biological analyte is separated and analyzed to distinguish cell states selected from the group consisting of normal cells, diseased cells, parasitized cells, cancer cells, foreign cells, and infected cells.

### Claim 16 (depends on 1)

The method of claim 1, wherein the sample comprises a plurality of analytes and each analyte migrates to a different location in the phase-separated system.

### Claim 17 (depends on 1)

The method of claim 1, wherein after migration, the analyte resides at a boundary location.

### Claim 18 (depends on 1)

The method of claim 1, wherein the boundary location is at an interface between a phase with a density greater than the density of the analyte and a phase with a density that is less than the density of the analyte.

### Claim 19 (depends on 1)

The method of claim 1, wherein after migration, the analyte resides within a phase of the phase-separated system whose density matches the density of the analyte.

### Claim 20 (depends on 1)

The method of claim 1, wherein the analyte/phase-separated system is centrifuged to accelerate migration of the analyte.

### Claim 21 (depends on 1)

The method of claim 1, wherein the analyte migrates under gravitational forces.

### Claim 22 (depends on 1)

The method of claim 1, wherein the analyte migrates under buoyancy forces.

### Claim 23 (depends on 1)

The method of claim 1, wherein the phase separated system is supported in a column or test tube.

### Claim 24 (depends on 1)

The method of claim 1, wherein the phase separated system is supported in a capillary tube, plastic test tube, falcon tube, culture tube, well plates, cuvette, along a filament, or on a sheet.

### Claim 25 (depends on 1)

The method of claim 1, wherein the surfactant is selected from the group consisting of polysorbate, CHAPS, polyoxyethylene-polyoxypropylene, 1-O-Octyl-β-D-glucopyranoside, 4-(1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol, 2-(Perfluoroalkyl)ethyl methacrylate, N,N-dimethyldodecylamine N-oxide, polyethylene glycol dodecyl ether, sodium dodecyl sulfate, sodium cholate, nonylphenol polyoxyethylene, benzylalkonium chloride, and dodecyltrimethylammonium chloride.

### Claim 26 (depends on 1)

The method of claim 1, wherein the polymer is selected from the group consisting of dextran, polysucrose, poly(vinyl alcohol), poly(2-ethyl-2-oxazoline), poly(methacrylic acid), poly(ethylene glycol), polyacrylamide, polyethyleneimine, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxy-polyacrylamide, poly(acrylic acid), poly(2-acrylamido-2-methyl-1-propanesulfonic acid), poly(diallyldimethyl ammonium chloride), poly(styrene sulfonic acid), polyallylamine, alginic acid, dextran sulfate, chondroitin sulfate A, diethylaminoethyl-dextran, poly(2-vinylpyridine-N-oxide), polydimethylsiloxane, and poly(propylene glycol).

### Claim 27 (depends on 1)

The method of claim 1, wherein the polymer or surfactant is selected from the group consisting CHAPS, polyoxyethylene-polyoxypropylene, dextran, polysucrose, poly(vinyl alcohol), poly(2-ethyl-2-oxazoline), poly(ethylene glycol), polyacrylamide, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxy-polyacrylamide, dextran sulfate, and poly(2-vinylpyridine-N-oxide).

### Claim 28 (depends on 1)

The method of claim 1, wherein the polymer is selected from the group of GRAS polymers.

### Claim 29 (depends on 1)

The method of claim 1, wherein the polymer is selected from the group of homopolymers, random copolymers, block copolymers, graft copolymers, ter-polymers, dendrimers, star polymers and combinations thereof.

### Claim 30 (depends on 29)

The method of claim 29, wherein the polymer is linear, branched and/or cross-linked.

### Claim 31 (depends on 1)

The method of claim 1, further comprising one or more additives selected from the group consisting of miscible surfactants, salts, dyes, nutrients, vitamins, antibiotics, anticoagulants, and buffers.

### Claim 32

A method of analyzing a sample comprising at least one analyte of interest using a multi-phase system, comprising:
a) providing a sample comprising at least one analyte of interest;
b) providing a multi-phase system comprising two or more phases with clear boundaries, wherein
at least one of the phases comprises a phase component, wherein the phase component is selected from the group consisting of a polymer, a surfactant, and combinations thereof;
each of the two or more phases has a different density and the two or more phases, taken together, represent a density gradient; and
the phases are phase-separated from each other; and
c) introducing the sample comprising a mixture of a tag molecule and the analyte to the multi-phase system, wherein the analyte and the tag molecule form a tag molecule-analyte adduct; and
d) allowing the tag molecule-analyte adduct to migrate to a location in the multiphase system that is characteristic of its density, wherein during migration the sample contacts one or more of the two or more phases sequentially and the analyte and the tag molecule-analyte adduct occupy different locations.

### Claim 33 (depends on 32)

The method of claim 32, wherein the tag molecule-analyte adduct is formed before or after the sample is introduced to the multi-phase system.

### Claim 34 (depends on 32)

A method of claim 32, wherein the sample comprises one or more biological analytes of interest.

### Claim 35 (depends on 32)

A method of claim 32, wherein the sample comprises one or more non-biological analytes of interest.

### Claim 36 (depends on 32)

A method of claim 32, wherein the multi-phase system comprises one or more biologically compatible phases.

### Claim 37 (depends on 32)

A method of claim 32, wherein the sample comprises the analyte of interest and one or more impurities, the impurity having the same density of the analyte, and the impurity having a different density than the tag molecule-analyte adduct.

### Claim 38 (depends on 32)

A method of claim 32, wherein the analyte of interest has an affinity for the tag molecule, and wherein the analyte of interest and tag molecule preferentially link to form a tag molecule-analyte adduct, the tag molecule-analyte adduct being linked by a method selected from the group consisting of covalent bonding, non-covalent bonding, hybridization, complexation, electrostatic interactions, and conjugation.

### Claim 39 (depends on 32)

A method of claim 32, wherein the tag in the tag molecule-analyte adduct has an affinity for one or more phase components, the tag of the tag molecule-analyte adduct and the phase component preferentially linking such that the tag molecule-analyte adduct preferentially aggregates in one or more phases containing phase components.

### Claim 40 (depends on 32)

A method of claim 32, wherein the analyte of interest is a cell selected from the group consisting of animal, plant, protozoan, and prokaryotic cells.

### Claim 41 (depends on 32)

A method of claim 32, wherein one or more phases cause the cells to lyse, and the biological analyte of interest being recovered from cell lysate.

### Claim 42 (depends on 32)

A method of claim 32, wherein the sample comprises one or more parasites selected from the group consisting of worms, insects, protozoa, arachnids, and arthropods.

### Claim 43 (depends on 32)

A method of claim 32, wherein the sample comprises one or biological carriers selected from the group consisting of whole blood, plasma, serum, sweat, feces, urine, saliva, tears, vaginal fluid, prostatic fluid, gingival fluid, amniotic fluid, intraocular fluid, cerebrospinal fluid, seminal fluid, sputum, ascites fluid, pus, nasopharengal fluid, wound exudate fluid, aqueous humour, vitreous humour, bile, cerumen, endolymph, perilymph, gastric juice, mucus, peritoneal fluid, pleural fluid, sebum, vomit, and combinations thereof.

### Claim 44 (depends on 40, 41, 42, 43)

A method according to any one of claims 40-43, wherein the analyte of interest is separated and analyzed to distinguish cell states selected from the group consisting of normal cells, diseased cells, parasitized cells, cancer cells, foreign cells, and infected cells.

### Claim 45 (depends on 32)

A method of claim 32, wherein the surfactant is selected from the group consisting of polysorbate, CHAPS, polyoxyethylene-polyoxypropylene, 1-O-Octyl-β-D-glucopyranoside, 4-(1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol, 2-(Perfluoroalkyl)ethyl methacrylate, N,N-dimethyldodecylamine N-oxide, polyethylene glycol dodecyl ether, sodium dodecyl sulfate, sodium cholate, nonylphenol polyoxyethylene, benzylalkonium chloride, and dodecyltrimethylammonium chloride.

### Claim 46 (depends on 32)

A method of claim 32, wherein the polymer is selected from the group consisting of dextran, polysucrose, poly(vinyl alcohol), poly(2-ethyl-2-oxazoline), poly(methacrylic acid), poly(ethylene glycol), polyacrylamide, polyethyleneimine, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxy-polyacrylamide, poly(acrylic acid), poly(2-acrylamido-2-methyl-1-propanesulfonic acid), poly(diallyldimethyl ammonium chloride), poly(styrene sulfonic acid), polyallylamine, alginic acid, dextran sulfate, chondroitin sulfate A, diethylaminoethyl-dextran, poly(2-vinylpyridine-N-oxide), polydimethylsiloxane, and poly(propylene glycol)

### Claim 47 (depends on 32)

A method of claim 32, wherein the polymer or surfactant is selected from the group consisting CHAPS, polyoxyethylene-polyoxypropylene, dextran, polysucrose, poly(vinyl alcohol), poly(2-ethyl-2-oxazoline), poly(ethylene glycol), polyacrylamide, hydroxyethyl cellulose, polyvinylpyrrolidone, carboxy-polyacrylamide, dextran sulfate, and poly(2-vinylpyridine-N-oxide).

### Claim 48 (depends on 46)

The method of claim 46, wherein the polymer is a type of polymer selected from the group consisting of a homopolymer, random copolymer, copolymer, terpolymer, block copolymer, linear polymer, branched polymer, random polymer, crosslinked polymer, and dendrimer system.

### Claim 49

A kit for separating a sample comprising one or more biological analytes of interest using a multi-phase system comprising:
a) two or more phase components selected from the group consisting of a polymer, a surfactant, and combinations thereof;
b) optionally a tag molecule capable of binding the one or more biological analytes of interest, wherein the tag molecule has a different density than the biological analyte of interest; and
c) instructions for:
(i) combining the two or more phase-separated solutions with a common solvent to create a multi-phase system;
(ii) optionally, combining the biological analyte of interest and tag molecule, and
(iii) separating the biological analyte of interest from the sample.

### Claim 50 (depends on 49)

The kit of claim 49, further comprising an aliquot of a common solvent which, when combined with the two or more phase components, provides a multiphase system.

### Claim 51 (depends on 49)

The kit of claim 49, wherein the instructions direct that the biological analyte of interest be combined with the tag molecule to form a tag molecule-analyte adduct before introduction to the multi-phase system.

### Claim 52 (depends on 49)

The kit of claim 49, wherein the instructions further direct that the biological analyte of interest and tag molecule be added to the multi-phase system to combine to form a tag molecule-analyte adduct in the multi-phase system.

### Claim 53 (depends on 49)

The kit of claim 49, wherein the kit further comprises one or more additives selected from the group consisting of miscible surfactants, salts, dyes, nutrients, vitamins, antibiotics, anticoagulants, and buffers for combination with the phase components.

### Claim 54 (depends on 49)

The kit of claim 49, wherein the multi-phase system comprises one or more biologically compatible phases.

### Claim 55 (depends on 49)

The kit of claim 49, wherein the kit comprises a tag that has an affinity for one or more analytes of interest.

### Claim 56 (depends on 49)

The kit of claim 49, wherein the kit comprises a tag that has an affinity for one or more phase components.

### Claim 57 (depends on 49)

The kit of claim 49, further comprising a lytic agent for introduction into one or more phases of the multiphase system.
